These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16630984)
1. Implantable cardioverter-defibrillator therapy in clinical practice. Cesario DA; Dec GW J Am Coll Cardiol; 2006 Apr; 47(8):1507-17. PubMed ID: 16630984 [TBL] [Abstract][Full Text] [Related]
2. Device based treatment of heart failure. Patwala AY; Wright DJ Postgrad Med J; 2005 May; 81(955):286-91. PubMed ID: 15879039 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
4. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy. Pires LA Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436 [TBL] [Abstract][Full Text] [Related]
5. Biventricular pacing and defibrillator use in chronic heart failure. Cesario DA; Turner JW; Dec GW Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163 [TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. Tung R; Zimetbaum P; Josephson ME J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736 [TBL] [Abstract][Full Text] [Related]
8. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351 [TBL] [Abstract][Full Text] [Related]
10. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063 [TBL] [Abstract][Full Text] [Related]
11. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use. Yarnoz MJ; Curtis AB Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376 [TBL] [Abstract][Full Text] [Related]
12. [Idiopathic dilated cardiomyopathy--an appraisal in 2005]. Antz M; Bänsch D Herz; 2005 Mar; 30(2):87-90. PubMed ID: 15875096 [TBL] [Abstract][Full Text] [Related]
13. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [TBL] [Abstract][Full Text] [Related]
14. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS; Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH; Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817 [TBL] [Abstract][Full Text] [Related]
16. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403 [TBL] [Abstract][Full Text] [Related]
17. How well are chronic heart failure patients being managed? Fonarow GC Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055 [TBL] [Abstract][Full Text] [Related]
18. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Ding L; Hua W; Niu H; Chen K; Zhang S Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335 [TBL] [Abstract][Full Text] [Related]
19. Sudden cardiac death in dialysis: do current guidelines for implantable cardioverter defibrillator therapy apply to patients with end-stage kidney disease? O'Shaughnessy MM; Lappin DW; Reddan DN Semin Dial; 2012 May; 25(3):272-6. PubMed ID: 22452711 [TBL] [Abstract][Full Text] [Related]